In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quest Diagnostics Incorporated

http://www.questdiagnostics.com/

Latest From Quest Diagnostics Incorporated

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.

Innovation In Vitro Diagnostics

Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217

The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.

Launches Commercial

Tasso Launches At-Home Blood Draw Platform For Trial Pre-Screening

Tasso has launched Tasso Care, a “scalable” blood data collection platform built around its unique at-home blood collection kit and screening data system.

Clinical Trials Business Strategies

News We’re Watching: Quest And CDC Partner On Hep C, Califf on Clinical Trials, Latest Recalls And Approvals

This week, Quest Diagnostics contracted with the CDC to research the public health impact of hepatitis C; FDA Commissioner Robert Califf published a blog post on clinical trial transparency; Dexcom and Abbott approached a deal in their CGM patent case; and SoClean, Cordis and Eitan all announced recalls.

Regulation Recalls
See All

Company Information

  • Industry
  • Services
    • Diagnostic Imaging Services
  • Other Names / Subsidiaries
    • ADI Holding Company
    • Athena Diagnostics
    • Blueprint Genetics
    • Boyce and Bynum Pathology Laboratories
    • California Laboratory Associates (CLA)
    • Celera Group
    • Cleveland HeartLab Inc.
    • ExamOne
    • Hurley Medical Center
    • Pathway Diagnostics
    • PhenoPath
    • Shiel Medical Laboratory
    • Solstas Lab Partners
    • Summit Health
    • Superior Mobile Medics
    • Mid America Clinical Laboratories (MACL)
UsernamePublicRestriction

Register